Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA
ContributorsBrahe, Cecilie Heegaard; Ørnbjerg, Lykke Midtbøll; Jacobsson, Lennart; Nissen, Michaël; Kristianslund, Eirik Klami; Mann, Herman; Santos, Maria José; Reino, Juan Gómez; Nordström, Dan; Rotar, Ziga; Gudbjornsson, Bjorn; Onen, Fatos; Codreanu, Catalin; Lindström, Ulf; Möller, Burkhard; Kvien, Tore K; Pavelka, Karel; Barcelos, Anabela; Sánchez-Piedra, Carlos; Eklund, Kari K; Tomšič, Matija; Love, Thorvardur Jon; Can, Gercek; Ionescu, Ruxandra; Loft, Anne Gitte; van der Horst-Bruinsma, I E; Macfarlane, Gary J; Iannone, Florenzo; Hyldstrup, Lise Hejl; Krogh, Niels Steen; Østergaard, Mikkel; Hetland, Merete Lund
Published inRheumatology
Publication date2019
Abstract
Keywords
- DAPSA28
- DAS28
- TNFi
- Drug survival
- Effectiveness
- Epidemiology
- Psoriatic arthritis
- Register
- Response
- Spondyloarthritis
Affiliation entities
Research groups
Citation (ISO format)
BRAHE, Cecilie Heegaard et al. Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. In: Rheumatology, 2019. doi: 10.1093/rheumatology/kez427
Main files (1)
Article (Published version)
Identifiers
- PID : unige:135495
- DOI : 10.1093/rheumatology/kez427
- PMID : 31665497
Journal ISSN1462-0324
